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Molecular pathogenesisPathogenesis following a virus infection results from interactions between the virus and its host. The outcome
is determined by tipping the balance between virulence of the virus or susceptibility/resistance of the host to
favor one or the other. This review focuses on two important members of the Old World arenavirus family:
Lassa fever virus (LFV), a robust human pathogen that causes a severe acute hemorrhagic disease; and
lymphocytic choriomeningitis virus (LCMV), also a human pathogen but better known in the context of its
rodent model. Research with this model has uncovered and illuminated many of our current concepts in
immunobiology and viral pathogenesis. Presented here are recent advances that form the framework for a
better understanding of how viruses induce and maintain persistent infection as well as for the pathogenesis
associated with acute LFV infection. A major component for understanding the pathogenesis of these
arenaviruses revolves around study of the interaction of virus with its receptor, alpha-dystroglycan (α-DG).tone),
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Viruses are studied for the diseases they cause, and also used as
probes for investigating basic biologic mechanism(s). The arenavirus
family contains a number of viruses like Lassa fever virus (LFV), Junin,
Machupo, Guanarito, and Sabia—important human pathogens that
cause hemorrhagic fever and a high incidence of death. Also in this
group is lymphocytic choriomeningitis virus (LCMV), which can cause
human disease but is best known for its use in research that has
successfully uncovered much of our current knowledge of viral
pathogenesis, viral persistence and a variety of areas of immunobiol-ogy including: immunologic tolerance, major histocompatibility
complex (MHC)-based recognition, CD8 and CD4 T cell activity,
T cell exhaustion, T and B cell-mediated immune memory, immune-
complex disease and virus-induced alteration of cellular differentia-
tion (“luxury”) functions.
The arenaviruses were initially subdivided into two major groups
based on serologic typing and phylogenetic evidence. This grouping
into Old World arenaviruses (LFV and LCMV) and New World
arenaviruses (Junin, Machupo, Guanarito, and Sabia) (Fig. 1A)
represents a distinction that has held up to study by genome
sequencing and monoclonal antibodies. The natural reservoirs of
arenaviruses are selected rodent species, in which the viruses are
most oftenmaintained as an asymptomatic, persistent infection that is
transmitted primarily by vertical/congenital routes. Spread to humans
is by contact with excreta from infected rodents or with infected
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occurred via laboratory accidents involving infected cell culture
material (i.e., LCMV infected cultures fail to exhibit evidence of
cytopathology), contact with asymptomatic pets (e.g., hamsters) that
are persistently infected with the virus, and by transplant-associated
infection (in immunocompromised patients). Indeed, arenaviruses
cause little or no toxicity to the cells they infect. The cell and tissue
injury–as well as resultant disease–associated with infection are
instead caused largely by activity of the immune system of the host,
whose antiviral response produces factors that act against and
damage virus-infected cells. An additional factor in pathology is the
displacement of cellular molecules that are normally attached to
cellular receptors by viral proteins; this can result in conformational
changes that cause the cell membrane to become fragile as well as
interference with normal signaling events.
Interestingly, although the arenaviruses naturally and preferen-
tially exist in a persistent state within their natural rodent hosts, the
ﬁrst arenavirus was isolated from a human (CG) who died of infection
during an outbreak of St. Louis encephalitis. Speciﬁcally, LCMV was
isolated by Charles Armstrong from a monkey that had been used as a
vehicle for passaging the infectious agent from this patient. The newly
isolated virus passed through a Berkefeld N ﬁlter and, when injected
intracerebrally (i.c.) into sentinel adult mice, caused rapid onset
(within 6 to 9 days) of a central nervous system (CNS) disease that
was characterized clinically by seizures and death (Armstrong and
Lillie, 1934). The histologic portrait was of lymphocytic inﬁltration in
the leptomeninges and choroid plexus which led to the virus' name
lymphocytic choriomeningitis virus (LCMV). On the basis of the
clinical incubation course, routes that caused infection, results of non-
overlapping antibody neutralization assays, and histopathologic
picture of CNS infection, LCMV was swiftly separated from the virus
that was responsible for St. Louis encephalitis. Two years later, Eric
Traub identiﬁed a persistent viral agent dwelling in white mice
without causing them apparent harm (Traub, 1935). That virus,
isolated by Traub through inoculation of other adult mice which did
not previously carry the virus, mimicked Charles Armstrong's isolate.
Both the prototype neurotropic LCMV Armstrong virus (ARM 53b)
and the prototype viral isolate from persistently infected mice (Cl 13)
were cloned and sequenced four decades later (Salvato et al., 1988,
1989).
Arenavirus binding to a cellular receptor and its entry into the cell
are initiated by the virus envelope glycoprotein (GP). This protein is
ﬁrst synthesized as a single polypeptide, the GP precursor (GPC), and
then undergoes proteolytic processing by the cellular proprotein SKI-
1/S1P (convertase subtilisin kexin isozyme-1/site-1 protease) result-
ing in two proteins: GP1 and GP2. GP1 is located on the GP spikes that
surround the virus, and interacts with its receptor on the host cell's
plasma membrane (Fig. 1A). GP2 is the transmembrane protein that
anchors GP1 to the virus surface. Virus binding to cellular receptors is
the key determinant of the physiologic outcome of infection. Alpha-
dystroglycan (α-DG) has been identiﬁed as the cellular receptor for
the Old World arenaviruses (LFV, LCMV, Mopeia, Mobala, and
presumably Lujo virus), as well as for the New World Clade
C arenaviruses Latino and Oliveros (Fig. 1B) (Cao et al., 1998). The
receptor for the New World Clade A and B arenavirus is transferin
receptor-1 (Radoshitzky et al., 2007). In this review, we will discuss
the mechanisms of infection and pathogenesis of the two best studies
of the Old World arenaviruses, LFV and LCMV.
In vivo selection of LCMV variants and molecular and biologic
mapping: a single amino acid change in viral GP1 and another in
the viral polymerase determine whether the virus causes an acute
self-limiting infection or a persistent infection
When LCMV infects its natural murine host, virus variants are
generated via organ-speciﬁc selection (Fig. 1C) (Ahmed and Oldstone,1988). Variants selected in the CNS are markedly dissimilar to those
selected in lymphoid tissues and cells (spleen, lymph nodes, dendritic
cells [DCs], CD4 and CD8 T cells) at both the biological and chemical
levels. Inoculation with ARM 53b–the virus cloned from the original
Armstrong isolate after multiple mouse-brain passages–into adult
immunocompetent mice subcutaneously (s.c.), intraperitoneally (i.p.),
or intravascularly (i.v.) leads to rapid emergence of virus-speciﬁc MHC-
restricted T cell responses in which CD8 T cells attack and remove the
virus-infected cells that serve as “factories” that produce infectious
virus. This results in rapid purging of the virus and clearance of the
infection. The result is quite different when ARM 53b is administered
intracerebrally (i.c.). Again, virus-speciﬁc CD8 T cells are generated, as i.
c. inoculation breaks through the blood–brain-barrier and the virus is
thus again introduced peripherally. At the same time, however, brain
cells–in particular those of the leptomeningeal and choroid plexus cells–
become infected. Ultimately, the virus-speciﬁc CD8 T cellsmigrate to the
CNS and interact directly with virus-infected cells (in the leptome-
ninges, choroid plexus, and endothelium), causing a lethal damage.
Speciﬁcally, they release cytokines and chemokines that attract
polymorphonuclear and mononuclear myeloid cells. The latter cell
types can destroy cells and in addition they release cytokines/
chemokines, which leads to an increase in intracerebral pressure that
kills the host (Kim et al., 2009). In the case of s.c., i.p., and i.v. inoculation
of ARM 53b, CNS injury and host death are avoided because the
cytotoxic T lymphocytes (CTLs) are generated before the virus can infect
CNS cells.
Organ-speciﬁc virus variants were generated by injecting cloned
ARM 53b into newborn mice less than 24 hours old. This resulted in a
life-long persistent infection. Virus variants isolated from the CNS of
adult mice, in which the virus persistently infects only neurons, were
similar to the wild-type ARM strain biologically. That is, these variants
(CTL+P− viruses) induced a potent and speciﬁc anti-LCMV CTL
response in adult mice, and the response cleared this infection within
twoweeks (Fig. 1C). In contrast, isolates cloned from lymphoid tissues
and cells, failed to generate a CTL response that was sufﬁcient to clear
the virus when injected i.v. into adult immunocompetent mice, and a
persistent infection followed (CTL-P+ viruses) (Fig. 1C). Viral clones
isolated from the CNS of mice originally infected with CTL-P+ virus
generated revertants with characteristics of the original ARM 53b
virus (CTL+P− virus). Thus, tissue- and cell-speciﬁc selection is
important in the evolution of these viruses, and suggests a mechanism
to account for the emergence of viral variants in nature.
An analysis of the sequences of over 50 of the lymphoid and
CNS variants revealed that CTL-P+ lymphoid variants commonly
encode an aliphatic small amino acid (predominantly leucine, but
occasionally isoleucine or valine), at position 260 of the GP1
protein. In contrast, CTL+P− variants have a bulky aromatic
phenylalanine at this position of GP1. In addition, sequencing of
the ARM 53b CTL+P− and Cl 13 CTL-P+ variants revealed a
difference in the polymerase gene (L) at residue 1079 with ARM
53b encoding a lysine and Cl 13 a glutamine (Salvato et al., 1991).
Although variants other than Cl 13 and ARM 53b were found to
encode alternative amino acids at various positions of the GP1 or
polymerase protein (Salvato et al., 1989, 1991; Sevilla et al., 2000),
these variants consistently featured the residue at GP1 position 260
that are consistent with their CTL response and permissiveness
status (i.e., positions GP1 260/L 1079: leucine/glutamine in CTL-P+ ;
phenylalanine/lysine in CTL+P-). Multiple studies, including reverse
genetics-based screens (Emonet, Sullivan, de la Torre, and Oldstone,
unpublished data), have shown that GP1 residue 260 is required
for binding to the α-DG receptor on DCs in order to initiate virus-
induced immunosuppression. Our knowledge of how residue 1079
causes persistent infection associated with CTL-P+ remains more
limited; given that the ﬁeld still lacks a polymerase assay, it has
not been possible to map the domains and functions of the LCMV
polymerase protein.
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variants and CTL+P− variants replicate to yield similar titers in the
spleen, (10−6 to 10−7 PFU at days 3 to 5 following infection with
2×10−6 PFU i.v.), replication occurred at different sites within this
organ (Sevilla et al., 2000; Smelt et al., 2001). In situ hybridization of
viral nucleic acid, as well as ﬂuorescence immunochemical micros-
copy for viral antigens carried out at early time points after infection
(days 1–3), revealed that the CTL-P+ variants localized to the white
pulp of the spleen whereas the CTL+P− variants localized primarily to
the red pulp and only minimally to the white pulp (Fig. 1C). Virus
overlay assays were then carried out. To this end, cultures containing
cells or tissues permissive to virus infection were prepared and
subjected to dounce homogenization, and the proteins were separat-
ed by polyacrylamide gel electrophoresis and transferred to nylon
membranes. These blots were incubated with either labeled of
unlabeled LCMV (Cl 13), and then with a monoclonal antibody to
LCMV GP. A broad band centered at roughly 116 kDa was revealed
(Fig. 1D). A range of enzymatic tests that followed identiﬁed the
material as a glycoprotein that did not contain lipid. With this
information in hand and a marker to identify the putative glycopro-
tein receptor, analysis involving a series of chromatographic steps
using ion-exchange and lectin columns resulted in puriﬁcation of a
single band that peptide proﬁling and mass spectrometry revealed to
be alpha-dystroglycan (α-DG) (Fig. 1B). Subsequent experiments
formally established α-DG as the receptor for LCMV, as well as for
other Old World and the New World Clade C arenaviruses. The
designation of α-DG as the receptor for these viruses was based on
three stringent criteria: (1) binding of the arenaviruses to puriﬁed α-
DG; (2) impaired binding between the arenavirus and α-DG in the
presence of soluble α-DG; and, most importantly, (3) the conversion
of cells lacking the α-DG gene from a permissive to a non-
permissiveness state with respect to infection, and restoration of
the permissive state by reintroduction of the α-DG gene (by either
transfection or adenovirus-mediated infection) (Cao et al., 1998; Kunz
et al., 2001; Smelt et al., 2001; Spiropoulou et al., 2002).
Molecular characterization of the Old World arenavirus receptor,
alpha-dystroglycan (α-DG), and how it dictates
arenavirus pathogenesis
Dystroglycan (DG) is a cell surface molecule that links proteins of
the extra-cellular matrix (ECM)–laminin, agrin, perlecan, and neur-
exin–with the internal actin-cytoskeletal machinery (Barresi and
Campbell, 2006; Ervasti and Campbell, 1991; Kunz, 2009) (Fig. 1B).
DG, which is encoded by a single gene, is post-translationally
processed to form an α subunit (α-DG) of 653 amino acids and a
β subunit (β-DG) of 242 amino acids. α-DG is non-covalently bound
to β-DG, and β-DG binds intracellularly to the cytoskeleton adapter
protein dystrophin, which links the DG complex to the actin-
cytoskeleton network. α-DG contains the binding site for Old World
arenaviruses, and the β subunit is not essential for the binding or
entry of virus, because entry occurs in the presence of either a deletion
mutant in which the β-DG cytoplasmic domain is absent or that of a
C-terminal fusion between α-DG and the transmembrane domain ofFig. 1. Panel A, top: high-resolution electron microscopy images of the LCMV arenavirus. The
surface. The central image shows several virions, and illustrates the arrangement of indivi
generated from and equally spaced around its center. The right image shows ribosomes that
the polymorphism and sloppiness of arenavirus budding (Oldstone, 2002). Panel A, bottom
indicate the ambisense strategy of transcription. The L (long) RNA encodes the Z (similar to
encodes a common GP that is cleaved post-translationally to produce GP1 (spike GP), GP2 (tr
complex. Panel B: schematic illustration of the structure of DG and themolecules that bind to
differential expression in (left panel) or absence from (right panel) the white pulp of the s
Oldstone, 1988; Sevilla et al., 2000; Smelt et al., 2001). Panel D: difference in afﬁnity of CTL-P
log higher afﬁnity than CTL+P− ARM 53b. Panel E: selective amounts ofα-DG on DCs (CD11c
Sevilla et al., 2000; Smelt et al., 2001). Panel F, top: schematic illustration of linear structur
LCMV, LFV and the ECMmolecule laminin indicated. Panel F, bottom: schematic depiction of
consequences of this modiﬁcation for interactions between the cell, ECM components andthe PDGF receptor (Kunz et al., 2003). The above-described studies
indicate that virus infection occurs regardless of whether the actin-
based cytoskeleton is intact. In several cell types, DG-associated
proteins–including dystrophin, utrophin, sarcospans andα, β, γ and δ,
and the sacroglycans–appear to be crucial for the stability and cellular
trafﬁcking of the DG complex (Fig. 1B), since mutations in the
encoding genes lead to loss of the DG receptor and membrane
stability, and to the development of neuromuscular diseases (Cohn,
2005; Kanagawa and Toda, 2006).
α-DG consists of N- and C-terminal globular protein heads that are
separated by amucin domainwhich can itself be divided into functional
N- and C-terminal regions (Fig. 1F). The binding site for LCMV, LFV and
the ECM molecule laminin has been mapped to an 18 amino acid
domain spanning residues 316-334, although it remains unclear
whether identical amino acids within this site are responsible for the
interactions with the two viruses and with laminin. Interestingly,
binding to Ca++,Mg++, and heparin is necessary for binding to laminin
but not forbinding tovirus (Kunzet al., 2001).However, virus binding to
α-DG requires that it displaces the ECM molecule. Competition assays
have revealed that CTL-P+ viruses out-compete the ECM molecule
laminin for binding by a factor of 4- to 6-fold; CTL+P− viruses, in
contrast, consistently fail to displace laminin (Kunzet al., 2001). Further,
when puriﬁed α-DG is placed on a membrane, CTL-P+ viruses bind
α-DG with an afﬁnity 2 to 2.5 logs higher than that of CTL+P− viruses
(Fig. 1D) (Kunz et al., 2001; Sevilla et al., 2000).
These observations describe two issues that are important for
understanding arenavirus-associated pathogenesis. First, those cells
in the body that express high levels ofα-DG aremost likely to bear the
burden and direct consequences of LCMV/LFV tropism and infection.
Second, since binding of α-DG to ECM molecules like laminin that
stabilizes the cell's membrane, interference with this interaction by
high afﬁnity-binding arenaviruses may destabilize the membrane.
Furthermore, this displacement may result in a loss of appropriate
signals and thus signiﬁcant disruption of cell function. As discussed
below, both viral tropism and ECM displacement play critical roles in
arenavirus pathogenesis.
The glycosyltransferase enzyme LARGE is an essential player in
arenavirus infection and pathogenesis (Kanagawa et al., 2004; Kunz
et al., 2005a, 2005b). In order to bind either ECM molecules or
arenaviruses, α-DG must be post-translationally modiﬁed by LARGE.
This post-translational modiﬁcation occurs within the N-terminal
region of the mucin domain (Fig. 1F). Additionally, the N-terminal
domain of α-DG interacts with LARGE. This two-fold interaction with
LARGE is believed to cause a change in the conformation of α-DG and
to lead to the modiﬁcation of a phosphorylated O-mannosyl glycan to
the mucin-like domain, thereby creating the binding site for
arenaviruses and ECM proteins (Yoshida-Moriguchi et al., 2010).
Interestingly, a recent genome survey in West Africa, where LFV is
endemic, revealed that polymorphisms in two genes that have been
functionally associated with the α-DG/DG receptor complex are
positively selected (Sabeti et al., 2007). The strongest signal was in a
22 kb region that lies entirely within the LARGE gene. The second
strong signal was in dystrophin, the adapter protein that links the C-
terminus of β-DG to the actin cytoskeleton network. The hypothesisleft-hand image shows the virion in its entirety, with the GP1 spikes protruding from its
dual spikes around a central core; each core has ﬁve spikes 27 mm in length, that are
are often incorporated into the virion; these play no role in virus replication, but reﬂect
: schematic diagrams show the four genes of the arenaviruses and their order. Arrows
matrix protein of paramyxoviruses), and L (polymerase) proteins. The S (short) RNA
ansmembrane GP), and NP (nucleoprotein). Together NP and L form the transcriptional
itsα and β chains. Panel C: organ selection of variants (●: CTL-P+;○: CTL+P−) and their
pleen when analyzed by using in situ viral nucleic acid hybridization (see Ahmed and
+ Cl 13 virus versus CTL+P− ARM 53b virus for puriﬁed α-DG. CTL-P+ Cl 13 binds at 2.5
+) but not T (CD4, CD8) or B (B200) cells isolated from the spleen (see Kunz et al., 2001;
e of the DG molecule, with its α and β subunits and the location of the binding site for
the actions of the glycosyltransferase LARGE as it binds to andmodiﬁesα-DG, and of the
virus.
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polymorphism in LARGE and/or dystrophin are likely to be less
susceptible to severe LFV infection, because the virus is less effective
at binding to α-DG, and thus also less effective at entering the cells.
Consequently, virus replication is less efﬁcient, and the immune
system has a competitive advantage in controlling virus infection.
Analysis of cells of the immune system indicates that dendritic
cells DCs primarily express the cellular receptor α-DG (Fig. 1E).
Biochemical study of spleens revealed that over 99% of α-DG was
associated with DCs, and less than 1% was associated with CD4 or CD8
T cells or with B cells. By selection, virus strains and variants that bind
α-DG with high afﬁnity are associated with virus replication in the
white pulp of the spleen, with preferential replication in a majority of
DCs. The consequence of mature DC infection is two-fold (Fig. 2). First,
MHC class I and II proteins, as well as the B7.1 and B7.2 costimulatory
molecules are markedly down-regulated (Fig. 2A) (Sevilla et al.,
2000). Second, there is a decrease in trafﬁcking of MHC molecules to
the DC surface (Fig. 2D). The outcome is a failure of DCs to present
viral antigens, and thus their failure to fully arm and expand immune-
speciﬁc T and B cells (Sevilla et al., 2000). As a result there is a global
suppression of anti-LCMV T cell as well as CTL responses to other
viruses including VSV and HSV, and suppression of antibody
responses to soluble or particulate antigens. In addition, the virus
induces infected DCs to produce negative regulators of the immune
system (Fig. 2B, C) (Brooks et al., 2006, 2008a, 2008b; Ejrnaes et al.,
2006). Several of these factors will be discussed below. The bottom
line is that the receptor (α-DG)–virus interaction on DCs in vivo is an
early and essential step in the commencement of virus-induced
immunosuppression and viral persistence.
Viruses have additional mechanisms for dismantling the host's DC-
T cell network, for example, interference with DC maturation and
migration (Sevilla et al., 2000, 2004). This phenomenon was ﬁrst
observed when LCMV Cl 13-infected hematopoietic progenitor cells
were found to be impaired in their development into DCs, both in vivo
and in vitro. This is a consequence of their production of IFN-α and
IFN-β (Sevilla et al., 2004) as DC progenitor cells in mice deﬁcient for
the receptor for IFNα/β still undergo differentiation into DCs even in
the context of virus infection. Other experiments in which adminis-
tration of the growth factor FLT-3 ligand resulted in dramatic
enhancement of the number of mature DCs. When either uninfected
or LCMVARM-infectedmicewere exposed to FLT-3 ligand for 10 days,
the number of common (c) DCs in the spleen was increased over 25-
fold. In contrast, when FLT-3 ligand was administered during Cl 13
infection, production of cDCs was not signiﬁcantly enhanced (b 2-fold
increase) (Sevilla et al., 2004).
In toto, the accumulated data indicates that Cl 13 (CTL-P+) virus
uses a 4-pronged strategy to ablate DC function and thereby establish
viral persistence. First, in the cases of both LCMV ARM and Cl 13
infections, a small but active set of LCMV-speciﬁc CD8+ CTLs is
generated early (days 4, 5). These CTLs destroy, at this time, the DCs
that present viral antigen on their surfaces; removal of CD8 T cells
with a speciﬁc monoclonal antibody against CD8 T cells is sufﬁcient to
prevent the development of persistent infection (Borrow et al., 1995).
Concurrently, Cl 13 can outcompete the ECM protein laminin for
binding to α-DG receptors on DCs, and then infects many of the
remaining DCs (Kunz et al., 2001; Sevilla et al., 2000). Once virus is
internalized into and replicatingwithin DCs, selective distortion of the
cell's transcriptional and translational machinery ensues, resulting in
the down-regulation of molecules that are required to present the
antigen (e.g., MHC class I and II complexes, costimulatory molecules)
and to thereby arm and expand T cell populations that could eliminate
the viral infection (Kunz et al., 2001; Sevilla et al., 2000; Smelt et al.,
2001). Third, the infected DCs are induced by the virus to produce
immune response suppressors such as IL-10 which might also act to
down-regulate class I MHC (Brooks et al., 2006, 2008a, 2008b; Ejrnaes
et al., 2006). Suchmolecules play a commanding role in turning off thefunction of (exhausting)most of the antiviral T cells that remain in the
periphery (Fig. 2C). Fourth, the virus prevents infected progenitor
cells from maturing into DCs and migrating to the spleen thereby
preventing the host from producing new DCs to reinforce the original
pool (Sevilla et al., 2004). Precisely at which stage of differentiation
DC progenitor cell(s) are infected is currently unknown, but this
question is being actively investigated in our laboratory (Ng,
Nussenzweig, and Oldstone, unpublished observations).
Recently others have suggested that CTL-P+ Cl 13 virus preferen-
tially, and most effectively, replicates in DC stromal cells:ﬁbroblastic
reticular cells (FRC) (Mueller et al., 2007). These cells are suspected to
express α-DG on their surfaces. FRCs have also been reported to
interact with the PD-1, a negative regulator of the immune response
(Mueller et al., 2007). The precise molecular events or molecules
engaged in the suspected immunosuppression are unknown, and
given that these FRCs comprise 0.4% or less of the total cell number in
the spleen, they are difﬁcult to investigate. Nevertheless, in the
interest of clarifying the roles and functions of FRCs, we have recently
isolated and immortalized pure populations of these cells (Ng, Nyak,
and Oldstone, unpublished data).
Over the last few years, attention has focused on the molecules
that are induced during persistent virus infection and negatively
regulate (suppress) the host's immune response. The two that have
been best characterized, IL-10 (Brooks et al., 2006, 2008a, 2008b;
Ejrnaes et al., 2006) and PD-1 (Barber et al., 2006; Blackburn et al.,
2010; Ha et al., 2008; Mueller et al., 2007), independently abrogate
antiviral CD8 and CD4 T cell function. Both molecules were found
originally during LCMV Cl 13 infections, and have now also been
identiﬁed in humans who suffer persistent infection with HIV, HBV
and HCV (Brockman et al., 2009; Kaufmann and Walker, 2008;
Martin-Blondel et al., 2009; Rutebemberwa et al., 2008). Recent
experiments have revealed the importance of the activities of IL-10
and PD-1 molecules with respect to the course of virus infection. In
fact, in the LCMVmodel, the application of antibodies against the IL-10
receptor (Brooks et al., 2006, 2008a, 2008b; Ejrnaes et al., 2006) and
PD-L1 (Barber et al., 2006; Blackburn et al., 2010; Ha et al., 2008) to
unresponsive “exhausted” T cells led to an in vivo rescue of T cell
function that was sufﬁcient to purge the persisting virus and control
the viral infection (Fig. 2E). Recovery of exhausted T cells in vitro has
also been achieved with antibodies against the IL-10 receptor and PD-
1 in persistent infections in humans (Brockman et al., 2009;
Kaufmann and Walker, 2008; Martin-Blondel et al., 2009; Rutebem-
berwa et al., 2008), and in vivo with an antibody against PD-1 in the
case of SIV infection (Velu et al., 2009). In addition, depletion and
reconstitution studies performed in vivo have established that TGFβ
(Tinoco et al., 2009), IL-21 (Elsaesser et al., 2009), and LAG3
(Blackburn et al., 2009) are important for suppressing the immune
response during persistent infection. Other suppressor molecules,
namely, CD160, 2B4, CTLA-4, PIR-B, GP49, KLRG1, NKG2A, NKG2D, and
BTLA were identiﬁed as inhibitory receptors, primarily on exhausted
CD8 T cells (Blackburn et al., 2009). All these molecules, as well as IL-
10, PD-1, IL-21, TGFβ, and LAG3, were found to be elevated–by gene
chip analysis of gene expression in Cl 13-infected DCs, CD4 T cells or
CD8 T cells, during the course of infection (at an initiation or during
maintained persistent infection)–when compared to molecules
harvested at similar time points from similar but uninfected or ARM
53b infected populations of immune cells.
In addition to the biased gene chip approach, in the case of the
LCMV Cl 13 model a non-biased forward genetic approach has been
used to identify novel negative regulators of the antiviral immune
response. This method uses ethylnitrosourea (ENU) to mutagenize
mice that are then challengedwith 1×106 PFU of LCMV Cl 13 i.v. At 15
or 30 days post-infection, non-mutanized normal mice will have
generated 4 to 6 logs of virus in their sera. In the genetic screen, mice
that have been ENU-mutagenized and infected with virus are
examined for limited or undetectable virus at those predetermined
Fig. 2. Panel A: schematic illustration of the ability of CTL-P+ virus Cl 13 to push aside ECM molecules from α-DG so that the virus can bind to its receptor site, preferentially infect DCs and, directed by its polymerase gene, replicate in DCs.
Consequences of virus replication are: 1) the production of negative regulators of the immune response, such as IL-10; 2) the down-regulation of MHC class I and II receptors (shown in Panel D for individual DCs) and their costimulatory
molecules B7.1 and B7.2; 3) a reduction in the development, migration, and expansion of new DCs due to the infection of precursor cells; and 4) a global suppression of the immune response. Also indicated is the inability of ARM 53b to
displace the ECMmolecule laminin. In the Cl 13 virus, the capacity to bind and enter DCs maps to the leucine residue at position 260 of the GP1 protein, whereas the enhanced replication of virus, once in the DC, is associated with glutamine at
position 1079 of the polymerase gene. Panel B shows that the negative immune regulator IL-10 is produced primarily by Cl 13-infected DCs and not during ARM 53b infection. Panel C illustrates that IL-10 abrogates the function of CD4 and CD8
T cells, a process that is reversed when antibodies to the IL-10 receptor (rec) are applied (see Brooks et al., 2006, 2008a, 2008b). Panel E: table summarizing restoration of anti-LCMV T cell function in the context of therapy with antibody to IL-
10rec (R) (based on data in Panel C); this works by purging the virus and terminating the infection in vivo. 175
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177M.B.A. Oldstone, K.P. Campbell / Virology 411 (2011) 170–179time points, indicating that genes encoding negative regulators of the
antiviral immune response have been knocked out. Thereafter,
breeding studies are performed to ensure that loss of the suppressor
factor is genetically transmitted, i.e., that the mutation is in the
germline. Once clearance of the virus is established as genetically
caused, deep sequencing or positional cloning is carried out. To date,
we have inoculated over 2,000 ENUmice and obtained 12 hits that are
currently under investigation (Popkin, Beutler, and Oldstone, unpub-
lished results). Based on these data, we calculate that roughly 100
such negative regulator molecules exist in the mouse and likely
human genomes.
Probing for mechanism(s) responsible for LFV pathogenesis and
for its clinical manifestations
LFV is endemic to West Africa, particularly Guinea, Liberia, Sierra
Leone, and Nigeria (Ogbu et al., 2007). An estimated 300,000 residents
in these localities incur infection each year, and approximately 20,000
to 30,000 deaths result from this (Fichet-Calvet and Rogers, 2009;
Ogbu et al., 2007). For about 80–90% of those infected with LFV, the
disease is mild, and recovery is associated with an anti-LFV immune
response, although approximately 20% of these survivors suffer from
permanent hearing loss (Cummins et al., 1990). This hearing
deﬁciency is believed to result from a sensory neuropathy, and is
the most common cause of hearing defects in West Africa. In addition,
approximately 20% of those infected with LFV suffer a severe disorder
affectingmultiple organ systems and, during epidemics, this can cause
a 50% or higher level of fatality. Of patients hospitalized for LFV
infection, 15% to 20% die from the illness. As a clinical marker, those
having serum titers of 8.5 log 10 PFU/ml of LFV or higher usually
succumb to the infection. The incubation period from contact with the
virus to the onset of illness can be as short as ﬁve or as long as 21 days.
In addition to fever, malaise, progressively worsening sore throat,
abdominal pain, and diarrhea, patients' suffer from leakage of blood
from small blood vessels (e.g., from capillaries due to needle
punctures made during hospital care) and from internal bleeding.
As bleeding worsens patients become delirious or confused, and some
convulse before dying. Thus, as shown in Fig. 3, three cardinal clinical
manifestations are in need of physiologic or molecular explanation
(Fig. 3A). In those individuals who are severely ill (many of whom
succumb to this disease) the ﬁrst sign is a high virus titer (N8.5 logs
PFU/ml of serum) in the absence of an effective immune response.
Second, vascular leakage occurs and leads to shock. In recovering
patients, blood levels of LFV during acute infection are lower than 8.5
logs PFU/ml, and third, with recovery comes a protective immune
response, but often, also the neurosensory hearing loss (Cummins
et al., 1990).
Much of our understanding of the pathogenesis of LFV is theoretical
and draws on lessons we have learned from LCMV Cl 13-like virus
infection based on the fact that both LFV and the LCMV CTL-P+ viruses
utilize α-DG as a receptor for attachment to and entry into cells (Cao
et al., 1998; Spiropoulou et al., 2002). DCs are themajor components of
the immune system that initiate the innate and adoptive antiviral
immune responses, and they are the essential point of contact for the
virus. Further, among the various cell populations that constitute the
immune response, DCs express the greatest amount of α-DG on their
surfaces (Fig. 1E) (Sevilla et al., 2000). Speciﬁcally,more than 99% of all
α-DG found in the immune system is present on DCs which are the
major antigen-presenting cells in the body. These cells are responsibleFig. 3. Experimental evidence supporting an important role for α-DG in LFV pathogenesis. Pa
and high mortality over the course of infection. Based on similarities to the LCMV Cl 13 m
response are believed the result of the ability of LFV to displace the ECMmolecule laminin, bin
cells, and serves as a receptor for LFV binding and entry (see Cao et al., 1998; Spiropoulou et a
dysfunction of their activity and the generation of suppressive factors that abort the host's
enhanced membrane fragility and instability (Panel B) (see Han et al., 2009, for details) and c
sheath (Panel C) (see Rambukkana et al., 2003, for details). The effects noted in Panels B anfor the processing and expression of viral peptides with MHC
molecules in order to present viral antigens and, in association with
costimulatory molecules for arming and expanding the virus-speciﬁc
immune response. As has been carefullyworked out and established in
the case of LCMV Cl 13 (see ii. above), we know that those viral strains
that bind α-DG with the highest afﬁnity and displace ECM molecules
like laminin preferentially infect DCs and alter their ability to initiate
an effective immune response (Oldstone, 2002; Sevilla et al., 2000;
Smelt et al., 2001). The consequence is suppression of both the innate
and adaptive antiviral immune responses, which leads to heightened
virus replication. A similar scenario is postulated, although not yet
proven to occur, in LFV-infected individuals who fail to develop an
effective antiviral immune response. This failure, coupled with an
elevation in viral titer as a consequence of unchecked replication,
results in the host being overwhelmed by the infection. Those LFV-
infected individuals who mount an immune response most often
survive the infection. The success or failure to mount an effective
immune response that clears the LFV infection is a likely attributable to
positive genetic selection (Sabeti et al., 2007). Recent biochemical
analysis of α-DG revealed that the cellular glycosyltransferase LARGE
is essential for adding a sugar unit to α-DG, thereby changing its
conformation to promote binding to LFV (Kunz et al., 2005a). This
information reinforces the above-mentioned observations from the
genomic survey in West Africa (Sabeti et al., 2007) that identiﬁed
positively selected polymorphisms in LARGE and dystrophin (the
protein that links the β-DG to the actin-cytoskeleton network), a
status associated with migration and stability of the α-DG complex.
Thus, if LFV binding toα-DG is decreased and causes diminished entry
of virus intoDCs as a result of defects in LARGEor dystrophin, the result
may be a selective advantage to the host. Then, as LFV replicates inDCs,
the antiviral immune response that is mounted has a better chance of
controlling the virus infection.
Although tropism and enhanced or limited binding and entry of LFV
into antigen-presenting cells is postulated to exert control over thevigor
of an antiviral adoptive immune response and susceptibility in one
person or resistance in another, it is tempting to postulate that the
associated vascular leakage and neurosensory loss may result as
consequences of a distinct but different mechanism. That sequence
may be one in which viruses displaces the ECM and causes membrane
instability (Han et al., 2009) (Fig. 3B), perhaps by disrupting GAP
junctions on endothelial cells, and/or by disturbing signaling emanating
from the ECM. Vascular leakage is associatedwith LFV replication in the
liver, an organ that produces many blood-clotting proteins whose
production is diminished during infection with LFV. Additionally, we
have observed that binding of inactivated virus (non-replicative) to
membranes displaces ECM laminin and leads to membrane instability
and leakage, as shown in Fig. 3B. This is similar to amechanism inwhich
binding of inactive LFV to the cell surface of Schwann cells disrupts
myelin formation, leading to demyelination (Fig. 3C) (Rambukkana et
al., 2003). In this paradigm, Schwann cells are coculturedwith rat axonal
cells. Under normal circumstances, ECM laminin signals lead via the
Schwann cells to the co-localization and deposition of myelin and
laminin around axons. However, when inactive LFV is bound to
Schwann cells, myelin formation is aborted, as judged by both electron
microscopy and immunohistochemical staining formyelin basic protein
(Fig. 3B). Similarly, laminin does not form along myelin sheaths, but
rather forms aggregates. Like LCMV, LFV is primarily a non-lytic virus
and does not destroy cells. Cell or tissue damage is instead caused by
immunopathologic mechanisms, by the distortion of ECM signals, or bynel A: correlation of serum titer (N8.5 logs PFU/ml) of LFV with vascular leakage, shock
odel (Figs. 1 and 2), LFV replication and the absence of an effective anti-LFV immune
d toα-DG and infect large numbers of DCs.α-DG is concentrated on antigen-presenting
l., 2002). The consequences of LFV replication in antigen-presenting cells likely lead to a
immune response. Panels B and C: displacement of the ECM molecule laminin leads to
ause a loss of signals that are required for the formation and maintenance of the myelin
d C have been documented with inactivated non-replicating virus.
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interference with their homeostatic function.
Conclusions
Arenaviruses per se cause little direct cell or tissue injury. Injury
accompanying arenavirus infection depends primarily on two factors.
The ﬁrst is production of the host antiviral immune response which is
meant to recognize, attack and remove infected cells that essentially
serve as virus-producing factories. The cell and tissue injury that can
result from this process cause the clinical manifestations of infection
during viral clearance. The pathologic outcome of tissue destruction
occurs when the immune response is too vigorous or takes place in a
vulnerable area such as the CNS. DCs are themajor antigen-presenting
cells and arm and expand the T and B cell populations needed to
attack virus-infected cells and to clear the infection. Viruses use a
multipronged strategy to disrupt DC function, thereby quieting the
antiviral immune response and promoting their own long-term
survival. This review documents how α-DG, the receptor for LCMV
and LFV, contributes to the pathogenesis of these viral infections.
Among the cells of the immune system, DCs express the highest levels
of α-DG and are the sentinel cells that LCMV, and presumably also
LFV, infect. The resultant infection of DCs compromises DC function.
When persistent infection arises, the consequences for the host are
alterations to the (“luxury”) functions of specialized cells, including
DCs, which lead to disordered homeostasis and disease (reviewed in
Oldstone, 2002). The second determinant of injury is the displace-
ment of laminin or other ECMmolecules that bind to the same site on
α-DG that LCMV and LFV seek. In pushing aside ECM molecules, the
virus destabilizes membranes and causes interference with ECM
signals that are required to maintain homeostasis. The end result is
disease manifestations that typify acute infection. The next level of
understanding of the molecular pathogenesis of these viruses will
require the identiﬁcation of the normal functions of such ECM signals.
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